Boehringer Ingelheim’s ‘CRM 360 Meeting’ brings together 300 medical experts

Boehringer Ingelheim’s ‘CRM 360 Meeting’ brings together 300 medical experts

- Over 300 nephrologists, endocrinologists, internists, diabetologists and cardiologists from India, the Middle East, and Africa attended the two-day meeting to tackle type 2 diabetes (T2D) and the interconnected cardiovascular, renal, and metabolic (CRM) systems.

- CRM conditions are the leading cause of death worldwide, accounting for up to 20 million deaths annually1

- The ‘CRM 360 Meeting’ is accredited by the American Association of Continuing Medical Education, the British Academy of Continuing Medical Education and notable local accrediting bodies

Dubai, United Arab Emirates: Over 300 healthcare professionals from India, the Middle East, and Africa joined international experts to share knowledge and best practice about the importance of taking a multidisciplinary approach to manage type 2 diabetes (T2D) at the ‘CRM 360 Meeting’ that was hosted by Boehringer Ingelheim, one of the world’s leading pharmaceutical companies, and took place in Dubai on October 21st and 22nd.

Cardiovascular, renal, and metabolic (‘CRM’) conditions affect more than one billion people worldwide and account for up to 20 million deaths annually, becoming the leading cause of death globally1. In the Middle East and North Africa, the prevalence of diabetes is at 55 million adults and is set to double by 20452. The pancreas, the heart, and the